Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basil S Lewis

Showing results (131-140 of 240) with videos related to

Pageof 24
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of CardiologyMorten Schmidt, Morten Lamberts, Anne-Marie Schjerning Olsen, et al.
Journal of the American College of Cardiology|June 15, 2007
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trialC Michael Gibson, Sabina A Murphy, Gilles Montalescot, et al.
Journal of the American Heart Association|January 19, 2017
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE TrialPeter T Hu, Renato D Lopes, Susanna R Stevens, et al.
Heart (British Cardiac Society)|January 21, 2018
Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve diseaseDragos Vinereanu, Alice Wang, Hillary Mulder, et al.
Journal of the American Heart Association|July 2, 2017
Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 TrialAlon Eisen, Christian T Ruff, Eugene Braunwald, et al.
Circulation|August 1, 2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trialP Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
JAMA Cardiology|November 9, 2017
Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical TrialRobert P Giugliano, Anthony Keech, Sabina A Murphy, et al.
Lancet (London, England)|December 10, 2013
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
Circulation|May 14, 2014
Response to letter regarding article, "Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial"P Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
Heart (British Cardiac Society)|September 17, 2020
Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillationAnthony P Carnicelli, Sana M Al-Khatib, Denis Xavier, et al.
Pageof 24

Showing results (131-140 of 240) with videos related to

Sort By:
Pageof 24
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of CardiologyMorten Schmidt, Morten Lamberts, Anne-Marie Schjerning Olsen, et al.
Journal of the American College of Cardiology|June 15, 2007
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trialC Michael Gibson, Sabina A Murphy, Gilles Montalescot, et al.
Journal of the American Heart Association|January 19, 2017
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE TrialPeter T Hu, Renato D Lopes, Susanna R Stevens, et al.
Heart (British Cardiac Society)|January 21, 2018
Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve diseaseDragos Vinereanu, Alice Wang, Hillary Mulder, et al.
Journal of the American Heart Association|July 2, 2017
Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 TrialAlon Eisen, Christian T Ruff, Eugene Braunwald, et al.
Circulation|August 1, 2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trialP Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
JAMA Cardiology|November 9, 2017
Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical TrialRobert P Giugliano, Anthony Keech, Sabina A Murphy, et al.
Lancet (London, England)|December 10, 2013
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
Circulation|May 14, 2014
Response to letter regarding article, "Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial"P Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
Heart (British Cardiac Society)|September 17, 2020
Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillationAnthony P Carnicelli, Sana M Al-Khatib, Denis Xavier, et al.
Pageof 24